Our data shows that FerroBio isolates a higher number of primitive hematopoietic stem cells (HSCs), even when total CD34+ counts are comparable. These more primitive cells are essential for long-term engraftment and regenerative outcomes—making FerroBio the ideal choice when potency matters most.